Dalawa umanong pharmaceutical companies sa bansa ang maaaring makagawa ng sarili nilang COVID-19 vaccine sa 2022 sa pamamagitan ng fill-and-finish vaccine manufacturing agreements, ayon sa Department of Science and Technology (DOST).
Sa pahayag ni DOST Undersecretary for Research and Development Rowena Cristina Guevara, anim na kumpanya ang nagpakita ng interes sa paggawa ng bakuna subalit dalawang kumpanya lamang umano ang agresibong matuloy ang planong ito.
“Meron kasi kami na nakikita na dalawang companies na medyo mabilis, e, aggressive, if they pursue, what we think are their plans based on what they told us, parang kakayanin nilang mag produce ng vaccines by late 2022,” ani Usec. Guevara.
Nagsimula umano ang pakikipag-ugnayan ng DOST sa pribadong sektor mula pa noong Abril 2020.
“Based on what we are hearing from the companies, it is possible by the end of 2022, meron sa kanilang makakapagproduce ng vaccines. It is possible, hindi pa talaga namin nafirm up ang timeline nila. Based on what they are presenting to us, mukhang possible,” ayon kay Usec. Guevara.
Paliwanag din niya, hindi umano lalampas ng dalawang taon ang paggawa ng bakuna sa ilalim ng fill-and-finish manufacturing agreement.
Aniya, ang prosesong ito ang huling yugto ng manufacturing process kung saan isasalin ang bakuna sa isang vial, ampule, o single-shot syringe para sa commercial distribution.
Anchored on its mantra, “Sentro ng Katotohanan, Tapat sa Mamamayan”, Balita Central Digital complements and supports the Balita Central newspaper published bi-monthly to combat fake news and to provide the public with easy-to-digest news bits that are sourced solely from the Presidency and government agencies.
Balita Central is under the supervision of the Bureau of Communications Services (BCS), one of the attached agencies of the Presidential Communications Operations Office (PCOO).
Launched on February 28, 2019 at the Manila Light Rail Transit System Line 2 (LRT-2) Cubao Station, Quezon City, it also aims to raise awareness among local communities about the policies, programs, and accomplishments of the Presidency.
Through this platform, Balita Central Digital aims to reach further the online community to deliver more accurate information and communication services in order to educate the citizenry regarding national issues which would enlighten them to be engaged and be empowered in contributing to building a better nation.
Balita Central is situated at the BCS Headquarters located beside the Philippine Cancer Society along San Rafael, San Miguel, Malacañang Complex, Manila City. Its official website address is balitacentral.ph.
For inquiries and feedback, Balita Central may be contacted at email@example.com.